BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 23212738)

  • 1. The role of metastasectomy in renal cell carcinoma in the era of targeted therapy.
    Ljungberg B
    Curr Urol Rep; 2013 Feb; 14(1):19-25. PubMed ID: 23212738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgery for metastases of renal cell carcinoma: outcome of treatments and preliminary assessment of Leuven-Udine prognostic groups in the targeted therapy era.
    Tornberg SV; Visapää H; Kilpeläinen TP; Taari K; Järvinen R; Erkkilä K; Nisen H; Järvinen P
    Scand J Urol; 2018; 52(5-6):419-426. PubMed ID: 30663485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of complete metastasectomy in metastatic renal cell carcinoma patients: The Canadian Kidney Cancer information system experience.
    Dragomir A; Nazha S; Wood LA; Rendon RA; Finelli A; Hansen A; So AI; Kollmannsberger C; Basappa NS; Pouliot F; Soulières D; Heng DYC; Kapoor A; Tanguay S
    Urol Oncol; 2020 Oct; 38(10):799.e1-799.e10. PubMed ID: 32778475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metastasectomy after targeted therapy in patients with advanced renal cell carcinoma.
    Karam JA; Rini BI; Varella L; Garcia JA; Dreicer R; Choueiri TK; Jonasch E; Matin SF; Campbell SC; Wood CG; Tannir NM
    J Urol; 2011 Feb; 185(2):439-44. PubMed ID: 21167518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical treatment of atypical metastasis from renal cell carcinoma (RCC).
    Antonelli A; Arrighi N; Corti S; Legramanti S; Zanotelli T; Cozzoli A; Cunico SC; Simeone C
    BJU Int; 2012 Dec; 110(11 Pt B):E559-63. PubMed ID: 22639956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgery for renal cell carcinoma metastases.
    Breau RH; Blute ML
    Curr Opin Urol; 2010 Sep; 20(5):375-81. PubMed ID: 20592612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extended hepatic metastasectomy for renal cell carcinoma-new aspects in times of targeted therapy: a single-center experience over three decades.
    Beetz O; Söffker R; Cammann S; Oldhafer F; Vondran FWR; Imkamp F; Klempnauer J; Kleine M
    Langenbecks Arch Surg; 2020 Feb; 405(1):97-106. PubMed ID: 31938833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment strategies for advanced renal cell carcinoma: A new paradigm for surgical treatment.
    Tomita Y
    Int J Urol; 2016 Jan; 23(1):13-21. PubMed ID: 26347163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of metastasectomy for metastatic renal cell carcinoma in the era of targeted therapy.
    Kim DY; Karam JA; Wood CG
    World J Urol; 2014 Jun; 32(3):631-42. PubMed ID: 24744223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of targeted therapy in combination with surgery in renal cell carcinoma.
    Bex A; Powles T; Karam JA
    Int J Urol; 2016 Jan; 23(1):5-12. PubMed ID: 26238981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted therapy after complete resection of metastatic lesions in metastatic renal cell carcinoma.
    Park YH; Jung JW; Lee BK; Lee S; Jeong SJ; Byun SS; Lee SE
    Int J Urol; 2015 Feb; 22(2):153-7. PubMed ID: 25421791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of RPLND and Metastasectomy in the Management of Oligometastatic Renal Cell Carcinoma.
    Nagaraja H; Srivatsa N; Hemalatha S; Shweta S; Raghunath SK
    Indian J Surg Oncol; 2018 Mar; 9(1):105-109. PubMed ID: 29563747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No role of adjuvant systemic therapy after complete metastasectomy in metastatic renal cell carcinoma?
    Kwak C; Park YH; Jeong CW; Lee SE; Ku JH
    Urol Oncol; 2007; 25(4):310-6. PubMed ID: 17628297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastasectomy in patients with renal cell carcinoma: when and how?
    Omid S; Abufaraj M; Remzi M
    Curr Opin Urol; 2020 Jul; 30(4):602-609. PubMed ID: 32464043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of surgery in advanced renal cell carcinoma: cytoreductive nephrectomy and metastasectomy.
    Karam JA; Wood CG
    Hematol Oncol Clin North Am; 2011 Aug; 25(4):753-64. PubMed ID: 21763966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastasectomy without systemic therapy in metastatic renal cell carcinoma: comparison with conservative treatment.
    Kwak C; Park YH; Jeong CW; Lee SE; Ku JH
    Urol Int; 2007; 79(2):145-51. PubMed ID: 17851285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of the primary tumor on the long-term results of pulmonary metastasectomy for metastatic renal cell carcinoma.
    Bölükbas S; Kudelin N; Eberlein M; Fisseler-Eckhoff A; Schirren J
    Thorac Cardiovasc Surg; 2012 Sep; 60(6):390-7. PubMed ID: 22207364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-modal treatment for metastatic renal cancer: the role of surgery.
    Russo P
    World J Urol; 2010 Jun; 28(3):295-301. PubMed ID: 20364382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Impact of Local Intervention Combined with Targeted Therapy on Metastatic Renal Cell Carcinoma.
    Li JR; Ou YC; Yang CK; Wang SS; Chen CS; Ho HC; Cheng CL; Yang CR; Chen CC; Wang SC; Lin CY; Hung SC; Hsu CY; Chiu KY
    Anticancer Res; 2018 Sep; 38(9):5339-5345. PubMed ID: 30194186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spinal metastasectomy of renal cell carcinoma: A 16-year single center experience with a minimum 3-year follow-up.
    Kato S; Murakami H; Demura S; Nambu K; Fujimaki Y; Yoshioka K; Kawahara N; Tomita K; Tsuchiya H
    J Surg Oncol; 2016 Apr; 113(5):587-92. PubMed ID: 26846902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.